1365 results
Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...
Crossing the finishing line - Latest best practices and technologies for large hole arterial and venous closure
14 May 2024 – From EuroPCR 2024
Tune in to this session for insights on optimizing vascular access and closure techniques. Explore steps like thorough CT analysis, ultrasound-guided puncture, and contingency plans for alternative access methods to minimize complications. Discover a novel patch-based closure approach offering immediate hemostasis and simplified usage, addressing issues...
Case closed: understanding the steps of vascular access and closure in TAVI patients
14 May 2024 – From EuroPCR 2024
Join this session to gain comprehensive insights on combining CT and echo guidance for optimal vascular access. Learn detailed steps for vascular closure using suture-mediated devices and explore the challenges and solutions associated with achieving successful suture-mediated vessel closure. This session will provide valuable knowledge and...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
How to overcome the most clinically relevant challenges in TAVI
14 May 2024 – From EuroPCR 2024
Watch this session to discover insights into patient-prosthesis mismatch and strategies to mitigate risks, delve into the significance of aortic valve commissure for coronary alignment optimization during TAVI, and explore solutions for common TAVI challenges such as peripheral vessel tortuosity and asymmetric valve calcifications in large...
TAVI in bicuspid stenosis: complex situations
14 May 2024 – From EuroPCR 2024
This session comprises selected clinical case submissions focused on TAVI (Transcatheter Aortic Valve Implantation) in patients with bicuspid aortic stenosis. Participants will learn about complex scenarios, including fusion raphe, hostile bicuspid anatomy, large annulus, and early TAVR dysfunction. The session features case presentations followed by audience...
Percutaneous valvular interventions and cardiogenic shock
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions focused on percutaneous valvular interventions in the context of cardiogenic shock. Learn about complex cases, including severe aortic stenosis with cardiogenic shock, transcatheter treatment of acute heart failure due to surgical prosthetic valve, and acute management of post-AMI papillary...
Critical aortic stenosis: what would you choose?
14 May 2024 – From EuroPCR 2024
This session, in collaboration with the GACI (French Group of Atheroma and Interventional Cardiology), Norwegian Working Group on Interventional Cardiology, and Dutch Working Group on Interventional Cardiology, presents three challenging cases of critical aortic stenosis. The cases include a patient with bicuspid aortic stenosis, a pregnant...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
TAVI in challenging anatomies
14 May 2024 – From EuroPCR 2024
Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...
TAVI updates: expanding indications
14 May 2024 – From EuroPCR 2024
This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...
How will the SMART trial results impact our practice and decision making in TAVI?
16 May 2024 – From EuroPCR 2024
Sabine Bleiziffer and Didier Tchétché discuss the SMART trial with Flavio Ribichini in this #europcr 2024 roundtable. The trial compares the self-expandable supra-annular EVOLUT platform and the balloon-expandable intra-annular SAPIEN platform in patients with small aortic annulus, prevalent in up to 40% of Europeans, mainly women....
Sensor-Guided TAVI using the SavvyWire Pre-Shaped Pressure Guidewire
16 May 2024 – From EuroPCR 2024
In this roundtable discussion, Ole De Backer and Danny Dvir explore the potential of the new SavvyWire to enhance #TAVI procedures by improving safety and efficiency while reducing the need for multiple manipulations. They also highlight how real-time left ventricle monitoring during procedures can lead to...
Clinical experience with DurAVR THV: a new class, biomimetic TAVI
16 May 2024 – From EuroPCR 2024
Join Azeem Latib, Christopher Meduri, and Nicolas Van Mieghem as they explore the history of cutting-edge tissue science in the TAVI space. Learn about the development of a biomimetic aortic valve design and insights from the DurAVR FIH study on this balloon-expandable platform. Discover the link...
What are the challenges for TAVI in bicuspid disease?
16 May 2024 – From EuroPCR 2024
Raj Makkar and Didier Tchétché address the complexities of bicuspid aortic valve disease, defining ideal candidates for TAVI or replacement and reviewing the NOTION-2 trial, which randomized younger, low-risk patients—including a significant number with bicuspid valves—to TAVI versus surgery. They highlight the importance of embolic protection...
Interventions for valvular disease: Highlights of EuroPCR 2024
16 May 2024 – From EuroPCR 2024
Christopher Cook hosts Nicolas Dumonteil and Bernard Prendergast as they share EuroPCR 2024 insights on valve disease interventions. Nicolas Dumonteil highlights record-breaking abstracts and cases, demonstrating expertise in TAVI, mitral, and tricuspid procedures. Bernard Prendergast emphasizes LIVE cases, especially in complex TAVI scenarios, reflecting everyday practice. Both stress...
What are the key considerations for first-time TAVI in a patient with long life expectancy?
15 May 2024 – From EuroPCR 2024
Interviewed by Dan Blackman, Philip Maccarthy discusses the rising trend of TAVI in younger patients and emphasizes optimizing first-TAVI procedure outcomes for long-term durability. He highlights considerations such as haemodynamics, low gradient, and minimizing paravalvular leak (PVL), as well as the importance of coronary access and...
NOTION-2: first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis
15 May 2024 – From EuroPCR 2024
Christopher Cook interviews Ole de Backer about this study he presented at EuroPCR 2024: It provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with TAVI compared to SAVR. TAVI and SAVR showed similar rates of the primary endpoint...
Asymptomatic severe aortic stenosis, how will new evidence change our practice?
15 May 2024 – From EuroPCR 2024
Victoria Delgado and Martin Leon discuss how to treat patients with asymptomatic severe aortic stenosis at an earlier stage and how current trials may change our practice in the future and broaden the indications.
This interview was filmed at EuroPCR 2024: see more videos here.
